Even though the drug has received approval for heart wellness use, not just weight loss, it’s frequently not covered. In the United States, Wegovy was previously only approved for use as a weight loss drug and was commonly not covered by health insurance plans. Now, the headline-making drug has also been approved in the country for heart health, but this isn’t expected to broaden availability for its coverage. The Novo Nordisk drug is taken by injection on a weekly basis As a prescription weight loss drug – one of only…
Read MoreTag: weight loss drugs
Health insurance could soon cover weight loss drug Wegovy
Novo Nordisk announced that the highly popular drug could have expanded FDA approval in six months. Novo Nordisk recently announced that its headline-making weight loss drug Wegovy could receive expanded US Food and Drug Administration (FDA) approval within six months, opening the door to much more readily available coverage by health insurance plans. The drug is already highly sought-after, but is not necessarily covered by most policies. Novo Nordisk’s chief financial officer Karsten Munk Knudsen said that the company’s application for approval of Wegovy as a cardiovascular disease reduction medication…
Read More